The global antithrombin market is primarily driven by the widespread use of antithrombin for the treatment of several medical conditions such as hereditary antithrombin deficiency, extracorporeal membrane oxygenation (ECMO), disseminated intravascular coagulation (DIC), and sepsis.
Albany, NY -- (SBWIRE) -- 11/28/2017 -- Recently, a new study titled "Antithrombin Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017 – 2025" has been added into the vast database of Market Research Reports Search Engine (MRRSE) that analyzes the global market for antithrombin right from historical trends to future prospects from the period 2017 to 2025, and presents 360 degree view to its readers.
Free Copy of Sample Report @ https://www.mrrse.com/sample/3800
According to the study, the global antithrombin market is expected to generate a revenue of US$ 704.5 mn by 2025 with a CAGR of 5.2% during the assessment period from 2017 to 2025. Additionally, the report also mentions that the global antithrombin market had generated revenue of US$ 448.2 mn in 2016.
The informative report has executive summary in the beginning that provides key information such as CAGR and another section for market overview shares details in terms of product overview, historical & forecast of market size from 2015 to 2025, key industry events, market opportunity map, porter's five forces and global antithrombin market outlook.
The report examines market dynamics for the global antithrombin market in order to understand the factors that drive the market, restraints, market opportunities, key trends and market snapshot. According to the report, the use of antithrombin in treatment of extracorporeal membrane oxygenation (ECMO), sepsis, disseminated intravascular coagulation (DIC) and hereditary antithrombin deficiency is one of the factors that drives the global antithrombin market.
Read Full Report with TOC @ https://www.mrrse.com/antithrombin-market
For detailed analysis of global antithrombin market, the report has been segmented into application, source, dosage form and region and shares analysis in terms of key findings, introduction, market value share analysis and market attractiveness analysis. The major application segments of global antithrombin market are therapeutics, research, and diagnostics. The therapeutics segment generates the highest revenue and held market share nearly 94.4% in 2016. The source segment is divided into human, goat milk, and others. The human segment generated revenue close to 88.6% of the overall market in 2016 and the segment is being followed by goat milk.
Antithrombin derived from goat milk is presently available in Europe and North America. As per report analysis, the availability of these products in Asia Pacific and Rest of the World is expected to boost the share of goat milk source segment during the assessment period.
The dosage form segment of global antithrombin market is categorized into lyophilized and liquid. As per report, the lyophilized dosage had a maximum market share in 2016 and generated a revenue that constituted almost 95.8% share of the global antithrombin market.
The region wise analysis and details on competition landscape also available in the report for new entrants and existing players in global antithrombin market.
Enquire About this Report @ https://www.mrrse.com/enquiry/3800
Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.
MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE's repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.
90, State Street
Albany, NY - 12207